K. Hathcock, G. Laszlo, C. Pucillo, P. Linsley, and R. Hodes, Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function, Journal of Experimental Medicine, vol.180, issue.2, pp.631-640, 1994.
DOI : 10.1084/jem.180.2.631

C. Rudd and H. Schneider, Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling, Nature Reviews Immunology, vol.3, issue.7, pp.544-556, 2003.
DOI : 10.1038/nri1131

H. Quill and R. Schwartz, Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness, J Immunol, vol.138, pp.3704-3712, 1987.

M. Brunner, C. Chambers, F. Chan, J. Hanke, A. Winoto et al., CTLA-4-Mediated inhibition of early events of T cell proliferation, J Immunol, vol.162, pp.5813-5820, 1999.

L. Chen, Co-inhibitory molecules of the B7???CD28 family in the control of T-cell immunity, Nature Reviews Immunology, vol.4, issue.5, pp.336-347, 2004.
DOI : 10.1038/nri1349

M. Croft, Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?, Nature Reviews Immunology, vol.3, issue.8, pp.609-620, 2003.
DOI : 10.1038/nri1148

B. Kwon, H. Lee, B. Kwon, P. Lau, and B. Ghumman, New insights into the role of 4-1BB in immune responses: beyond CD8+ T cells 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy, Role of 4-1BB:4-1BB ligand in cancer immunotherapy, pp.378-3801313, 2001.

D. Pardoll, ?, Annual Review of Immunology, vol.21, issue.1, pp.807-839, 2003.
DOI : 10.1146/annurev.immunol.21.120601.141135

J. Schultze, L. Nadler, and J. Gribben, B7-mediated costimulation and the immune response, Blood Reviews, vol.10, issue.2, pp.111-127, 1996.
DOI : 10.1016/S0268-960X(96)90040-5

K. Hellstrom and I. Hellstrom, Therapeutic vaccination with tumor cells that engage CD137, Journal of Molecular Medicine, vol.61, issue.2, pp.71-86, 2003.
DOI : 10.1073/pnas.092123699

I. Melero, W. Shuford, and S. Newby, Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors, Nature Medicine, vol.183, issue.6, pp.682-685, 1997.
DOI : 10.1146/annurev.immunol.12.1.635

O. Martinet, C. Divino, and Y. Zang, T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer, Gene Therapy, vol.9, issue.12, pp.786-792, 2002.
DOI : 10.1038/sj.gt.3301687

M. Attal, J. Harousseau, and A. Stoppa, A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma, New England Journal of Medicine, vol.335, issue.2, pp.91-97, 1996.
DOI : 10.1056/NEJM199607113350204

K. Tarte, X. Zhang, and E. Legouffe, Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells, J Immunol, vol.163, pp.514-524, 1999.

X. Zhang, J. Gaillard, and N. Robillard, Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma The defect in peripheral blood B-cell activation in patients with multiple myeloma is not due to a deficiency in the production of B-cell growth and differentiation factors, Blood. J Clin Immunol, vol.839, issue.19, pp.3654-366365, 1989.

R. Sun, Z. Lu, and J. Wijdenes, Large scale and clinical grade purification of syndecan-1+ malignant plasma cells, Journal of Immunological Methods, vol.205, issue.1, pp.73-79, 1997.
DOI : 10.1016/S0022-1759(97)00056-2

K. Tarte, G. Fiol, J. Rossi, and B. Klein, Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Leukemia. Anal Biochem, vol.14162, issue.21, pp.2182-2192156, 1987.

C. Ferrand, R. E. Contassot, and E. , Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire Malignant plasma cell lines express a functional CD28 molecule, Hum Gene Ther. Leukemia, vol.1112, issue.24, pp.1151-1164610, 1998.

B. Pope, R. Brown, J. Gibson, E. Yuen, J. D. Futagawa et al., B7-2-positive myeloma: incidence, clinical characteristics, prognostic significance, and implications for tumor immunotherapy Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells, Blood. Int Immunol, vol.9614, issue.26, pp.1274-1279275, 2000.

G. Missale, A. Redeker, and J. Person, HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis, Journal of Experimental Medicine, vol.177, issue.3, pp.751-762, 1993.
DOI : 10.1084/jem.177.3.751
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190933

J. Sidney, M. Del-guercio, and S. Southwood, Several HLA alleles share overlapping peptide specificities Pellat-Deceunynck C. Tumour-associated antigens in multiple myeloma, J Immunol. Br J Haematol, vol.154120, issue.29, pp.247-2593, 1995.

M. Hundemer, S. Schmidt, and M. Condomines, Identification of a new HLA-A2???restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma, Experimental Hematology, vol.34, issue.4, pp.486-496, 2006.
DOI : 10.1016/j.exphem.2006.01.008
URL : https://hal.archives-ouvertes.fr/inserm-00131759

I. Melero, N. Bach, K. Hellstrom, A. Aruffo, R. Mittler et al., Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway, European Journal of Immunology, vol.89, issue.3, pp.1116-1121, 1998.
DOI : 10.1002/(SICI)1521-4141(199803)28:03<1116::AID-IMMU1116>3.0.CO;2-A

B. Guinn, M. Debenedette, T. Watts, N. Berinstein, M. Dudley et al., 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine Adoptive cell transfer therapy following nonmyeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma, J Immunol. J Clin Oncol, vol.16223, issue.33, pp.5003-50102346, 1999.

N. Meidenbauer, J. Marienhagen, and M. Laumer, Survival and Tumor Localization of Adoptively Transferred Melan-A-Specific T Cells in Melanoma Patients, The Journal of Immunology, vol.170, issue.4, pp.2161-2169, 2003.
DOI : 10.4049/jimmunol.170.4.2161

C. Yee, J. Thompson, and D. Byrd, Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells, Proceedings of the National Academy of Sciences, vol.71, issue.2, pp.16168-16173, 2002.
DOI : 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0

A. Cignetti, A. Vallario, and A. Follenzi, Lentiviral Transduction of Primary Myeloma Cells with CD80 and CD154 Generates Antimyeloma Effector T Cells, Human Gene Therapy, vol.16, issue.4, pp.445-456, 2005.
DOI : 10.1089/hum.2005.16.445

J. Bukczynski, T. Wen, K. Ellefsen, J. Gauldie, and T. Watts, Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses, Proceedings of the National Academy of Sciences, vol.8, issue.1, pp.1291-1296, 2004.
DOI : 10.1038/nm0102-47

J. Piskurich, K. Lin, Y. Lin, Y. Wang, J. Ting et al., CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells, Nature. Nat Immunol, vol.4211, issue.39, pp.852-856526, 2000.

N. Ghosh, I. Gyory, G. Wright, J. Wood, and K. Wright, Positive Regulatory Domain I Binding Factor 1 Silences Class II Transactivator Expression in Multiple Myeloma Cells, Journal of Biological Chemistry, vol.276, issue.18, pp.15264-15268, 2001.
DOI : 10.1074/jbc.M100862200

P. Silacci, A. Mottet, V. Steimle, W. Reith, and B. Mach, Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA, Journal of Experimental Medicine, vol.180, issue.4, pp.1329-1336, 1994.
DOI : 10.1084/jem.180.4.1329

C. Germeau, W. Ma, and F. Schiavetti, High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens, The Journal of Experimental Medicine, vol.58, issue.2, pp.241-248, 2005.
DOI : 10.1126/science.1076514

M. Feuerer, P. Beckhove, and N. Garbi, Bone marrow as a priming site for T-cell responses to blood-borne antigen, Nature Medicine, vol.9, issue.9, pp.1151-1157, 2003.
DOI : 10.1038/nm914

Q. Li, A. Carr, F. Ito, S. Teitz-tennenbaum, and A. Chang, Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy, Cancer Res, vol.63, pp.2546-2552, 2003.

R. Mittler, T. Bailey, K. Klussman, M. Trailsmith, and M. Hoffmann, Anti-4-1BB Monoclonal Antibodies Abrogate T Cell-dependent Humoral Immune Responses In Vivo through the Induction of Helper T Cell Anergy, Journal of Experimental Medicine, vol.190, issue.10, pp.1535-1540, 1999.
DOI : 10.1084/jem.190.10.1535

L. Myers, C. Takahashi, R. Mittler, R. Rossi, and A. Vella, Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering, Proceedings of the National Academy of Sciences, vol.168, issue.1, pp.5348-5353, 2003.
DOI : 10.1111/j.1600-065X.1999.tb01300.x